Mouwasat posts higher net profit at SAR 117.4mln in I2 of 2014

30/06/2014 Argaam Exclusive

View other reports

Share Price

120.00
(1.20) (0.99 %)

Mouwasat Medical Services Co. (MOUWASAT)

 

Mouwasat Medical Services Co., active in the operation and management of hospitals and medical clinics, reported SAR 117.4mln net profit at the end of the first half of 2014, a 10% increase compared to the same period last year.



Financials (M)

Item 6m 2013 6m 2014 Change‬
Revenues 447.96 487.79 8.9 %
Gross Income 227.29 248.32 9.3 %
Operating Income 118.21 126.18 6.7 %
Net Income 106.67 117.39 10.0 %
Average Shares 200.00 200.00 -
EPS (Riyals) 0.53 0.59 10.0 %


Current Quarter Comparison (M)

Compared With The
Item Q2 2013 Q2 2014 Change‬
Revenues 228.74 244.25 6.8 %
Gross Income 116.90 124.14 6.2 %
Operating Income 59.96 63.22 5.4 %
Net Income 54.16 59.44 9.8 %
Average Shares 200.00 200.00 -
EPS (Riyals) 0.27 0.30 9.8 %


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2005 - - - - - - -
Q2 2005 - - - - - - -
Q3 2005 - - - - - - -
Q4 2005 - - - - - - -
Q1 2006 - - - - - - -
Q2 2006 - - - - - - -
Q3 2006 - - - - - - -
Q4 2006 - - - - - - -
Q1 2007 - - - - - - -
Q2 2007 - - - - - - -
Q3 2007 - - - - - - -
Q4 2007 - - - - - - -
Q1 2008 113.83 - 52.37 - 25.90 - 0.13
Q2 2008 118.48 - 53.79 - 26.63 - 0.13
Q3 2008 104.92 - 47.23 - 20.47 - 0.10
Q4 2008 117.32 - 47.51 - 24.07 - 0.12
Q1 2009 124.60 9.5 % 56.25 7.4 % 26.55 2.5 % 0.13
Q2 2009 140.62 18.7 % 67.77 26.0 % 34.03 27.8 % 0.17
Q3 2009 115.21 9.8 % 54.05 14.4 % 21.88 6.9 % 0.11
Q4 2009 137.16 16.9 % 49.94 5.1 % 24.58 2.1 % 0.12
Q1 2010 143.79 15.4 % 68.04 21.0 % 32.37 21.9 % 0.16
Q2 2010 148.78 5.8 % 71.36 5.3 % 34.77 2.2 % 0.17
Q3 2010 134.72 16.9 % 63.30 17.1 % 23.14 5.8 % 0.12
Q4 2010 160.20 16.8 % 74.36 48.9 % 28.28 15.1 % 0.14
Q1 2011 166.82 16.0 % 84.05 23.5 % 39.14 20.9 % 0.20
Q2 2011 164.93 10.9 % 76.76 7.6 % 40.49 16.4 % 0.20
Q3 2011 156.92 16.5 % 74.10 17.1 % 33.71 45.7 % 0.17
Q4 2011 189.77 18.5 % 89.09 19.8 % 34.72 22.8 % 0.17
Q1 2012 195.57 17.2 % 94.32 12.2 % 46.34 18.4 % 0.23
Q2 2012 200.62 21.6 % 93.28 21.5 % 47.26 16.7 % 0.24
Q3 2012 187.28 19.3 % 84.01 13.4 % 35.44 5.1 % 0.18
Q4 2012 213.04 12.3 % 101.10 13.5 % 42.56 22.6 % 0.21
Q1 2013 219.23 12.1 % 110.39 17.0 % 52.52 13.3 % 0.26
Q2 2013 228.74 14.0 % 116.90 25.3 % 54.16 14.6 % 0.27
Q3 2013 211.63 13.0 % 104.34 24.2 % 44.11 24.5 % 0.22
Q4 2013 242.64 13.9 % 124.17 22.8 % 50.42 18.4 % 0.25
Q1 2014 243.54 11.1 % 124.18 12.5 % 57.94 10.3 % 0.29
Q2 2014 244.25 6.8 % 124.14 6.2 % 59.44 9.8 % 0.30

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2005 - - -
Q2 2005 - - -
Q3 2005 - - -
Q4 2005 - - -
Q1 2006 - - -
Q2 2006 - - -
Q3 2006 - - -
Q4 2006 - - -
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 44.20 % 30.76 % 21.36 %
Q1 2009 44.01 % 30.89 % 21.00 %
Q2 2009 44.88 % 32.07 % 21.57 %
Q3 2009 45.32 % 32.67 % 21.40 %
Q4 2009 44.05 % 30.06 % 20.68 %
Q1 2010 44.67 % 30.72 % 21.03 %
Q2 2010 44.66 % 30.02 % 20.85 %
Q3 2010 44.76 % 28.94 % 20.35 %
Q4 2010 47.16 % 30.15 % 20.18 %
Q1 2011 48.00 % 29.97 % 20.53 %
Q2 2011 47.63 % 29.54 % 20.91 %
Q3 2011 47.66 % 30.31 % 21.83 %
Q4 2011 47.76 % 30.40 % 21.82 %
Q1 2012 47.27 % 30.32 % 21.95 %
Q2 2012 47.22 % 30.30 % 21.81 %
Q3 2012 46.65 % 28.88 % 21.18 %
Q4 2012 46.79 % 28.28 % 21.54 %
Q1 2013 47.40 % 28.13 % 21.68 %
Q2 2013 48.62 % 28.20 % 21.77 %
Q3 2013 49.59 % 28.72 % 22.16 %
Q4 2013 50.52 % 29.11 % 22.30 %
Q1 2014 50.68 % 28.86 % 22.30 %
Q2 2014 50.62 % 28.77 % 22.49 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2005 - - - -
Q2 2005 - - - -
Q3 2005 - - - -
Q4 2005 - - - -
Q1 2006 - - - -
Q2 2006 - - - -
Q3 2006 - - - -
Q4 2006 - - - -
Q1 2007 - - - -
Q2 2007 - - - -
Q3 2007 - - - -
Q4 2007 - - - -
Q1 2008 200.00 - - 1.90
Q2 2008 200.00 - - 1.92
Q3 2008 200.00 - - 2.02
Q4 2008 200.00 0.49 0.49 2.05
Q1 2009 200.00 0.49 0.49 2.18
Q2 2009 200.00 0.53 0.53 2.27
Q3 2009 200.00 0.53 0.53 2.28
Q4 2009 200.00 0.54 0.54 2.40
Q1 2010 200.00 0.56 0.56 2.56
Q2 2010 200.00 0.57 0.57 2.61
Q3 2010 200.00 0.57 0.57 2.72
Q4 2010 200.00 0.59 0.59 2.86
Q1 2011 200.00 0.63 0.63 3.06
Q2 2011 200.00 0.66 0.66 3.01
Q3 2011 200.00 0.71 0.71 3.18
Q4 2011 200.00 0.74 0.74 3.34
Q1 2012 200.00 0.78 0.78 3.57
Q2 2012 200.00 0.81 0.81 3.44
Q3 2012 200.00 0.82 0.82 3.61
Q4 2012 200.00 0.86 0.86 3.82
Q1 2013 200.00 0.89 0.89 4.08
Q2 2013 200.00 0.92 0.92 3.98
Q3 2013 200.00 0.97 0.97 4.20
Q4 2013 200.00 1.01 1.01 4.44
Q1 2014 200.00 1.03 1.03 4.73
Q2 2014 200.00 1.06 1.06 4.53

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2005 - - -
Q2 2005 - - -
Q3 2005 - - -
Q4 2005 - - -
Q1 2006 - - -
Q2 2006 - - -
Q3 2006 - - -
Q4 2006 - - -
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 14.20 14.20 3.31
Q4 2009 14.31 14.31 3.19
Q1 2010 13.68 13.68 3.02
Q2 2010 14.64 14.64 3.19
Q3 2010 14.75 14.75 3.11
Q4 2010 15.18 15.18 3.15
Q1 2011 13.52 13.52 2.77
Q2 2011 16.08 16.08 3.50
Q3 2011 13.29 13.29 2.96
Q4 2011 15.92 15.92 3.53
Q1 2012 16.83 16.83 3.66
Q2 2012 13.89 13.89 3.27
Q3 2012 15.57 15.57 3.53
Q4 2012 15.66 15.66 3.52
Q1 2013 18.00 18.00 3.92
Q2 2013 18.62 18.62 4.32
Q3 2013 21.21 21.21 4.88
Q4 2013 22.86 22.86 5.18
Q1 2014 21.78 21.78 4.75
Q2 2014 24.19 24.19 5.66

Business Segments (Million)

Compared With The
Period Medical Services Pharmaceutical Products Administration Fees
Q1 2008 86.60 26.81 0.43
Q2 2008 91.71 26.38 0.40
Q3 2008 84.21 20.23 0.47
Q4 2008 84.07 31.65 1.61
Q1 2009 94.61 29.63 0.36
Q2 2009 105.22 28.44 6.97
Q3 2009 92.73 26.15 (3.67)
Q4 2009 103.72 33.04 0.40
Q1 2010 109.41 32.47 1.92
Q2 2010 114.73 34.05 -
Q3 2010 102.85 31.87 -
Q4 2010 118.91 41.29 -
Q1 2011 129.63 37.19 -
Q2 2011 128.04 36.89 -
Q3 2011 123.09 33.84 -
Q4 2011 149.24 40.52 -
Q1 2012 155.38 40.19 -
Q2 2012 159.24 41.38 -
Q3 2012 149.51 37.77 -
Q4 2012 168.11 44.93 -
Q1 2013 177.18 42.05 -
Q2 2013 186.71 42.02 -
Q3 2013 172.61 39.02 -
Q4 2013 182.05 45.21 -
Q1 2014 196.67 46.87 -
Q2 2014 198.14 46.10 -

Current
Market Cap (M Riyal) 24,000.00
Enterprise Value (EV) (M) 24,766.83
Shares Outstanding ((M)) 200.00
EPS ( Riyal) (TTM) 3.30
Book Value (BV) ( Riyal) 17.24
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 36.41
P/E (TTM) 36.41
Price/book 6.96
Return on Average Assets (%) (TTM) 13.5
Return on Average Equity (%) (TTM) 20.2

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.